OmniAb (OABI) Accounts Payables (2021 - 2026)
OmniAb (OABI) posted quarterly Accounts Payables of $1.7 million for Q1 2026, down 14.54% year-over-year from $1.9 million in Q1 2025, and down 12.08% quarter-over-quarter from $1.9 million in Q4 2025.
OmniAb (OABI) Accounts Payables (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Accounts Payables for 6 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 14.54% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 14.54% YoY), while the FY2025 annual figure was $1.9 million, down 18.2% from the prior year.
- Accounts Payables slipped to $1.7 million in Q1 2026 per OABI's latest filing, from $1.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.3 million in Q3 2022 and bottomed at $370376.0 in Q1 2022.
- Historically, Accounts Payables has averaged $2.7 million across 5 years, with a median of $2.4 million in 2023.
- Annual changes were most pronounced in 2022 — Accounts Payables surged 18830.76% — and 2023, when it sank 60.32%.
- OmniAb's Accounts Payables stood at $3.0 million in 2022, then surged by 48.47% to $4.4 million in 2023, then sank by 47.93% to $2.3 million in 2024, then fell by 18.2% to $1.9 million in 2025, then decreased by 12.08% to $1.7 million in 2026.
- Business Quant data shows OABI's Accounts Payables at $1.7 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | 2.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.09 Mn |
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 3.56 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 6.30 Mn |
| Jun 30, 2022 | 4.54 Mn |
| Mar 31, 2022 | 370,376.00 |
| Dec 31, 2021 | 2.92 Mn |
| Sep 30, 2021 | 33,292.00 |